Cinchona officinalis Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | C. robusta How. |
| Family | Rubiaceae. |
| Habitat | Cultivated in West Bengal and Tamil Nadu. |
| English | Crown or Loxa Bark. |
| Ayurvedic | Quinine. |
| Unani | Al-keenaa, Kanakanaa. |
| Action | Antimalarial, febrifuge, astringent, orexigenic, sapasmolytic. Also prescribed in amoebic dysentery, jaundice, atonic dyspepsia, night cramps. Sometimes causes gastric and intestinal irritation. |
| Key Application | In peptic discomforts such as bloating and fullness, loss of appetite. (German Commission E.) |
| Taxonomic Cohort | Genus Cinchona (1 documented species); Family Rubiaceae (40 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Cinchona officinalis (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Rubiaceae (primary family classification: Rubiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. robusta How, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Cultivated in West Bengal and Tamil Nadu.
Across classical and vernacular Indian systems of medicine, Cinchona officinalis is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Crown or Loxa Bark; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Quinine; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Al-keenaa, Kanakanaa. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Cinchona officinalis are: Antimalarial, febrifuge, astringent, orexigenic, sapasmolytic. Also prescribed in amoebic dysentery, jaundice, atonic dyspepsia, night cramps. Sometimes causes gastric and intestinal irritation. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: In peptic discomforts such as bloating and fullness, loss of appetite. (German Commission E.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Cinchona officinalis establish the following evidence base: The bark contains alkaloids quinine (2.35–4.42%); quinidine (1.44–2.56%); cinchonine (0.10–0.66%); cinchonidine (0.49–0.89%) and other alkaloids, quinamine, javanine (0.14–0.63%). The leaves contain quercetin, kaempferol and avicularin. Quinine is antimalarial; quinidine is antiarrhythmic and cardiac tonic, also used in psychic treatments. The bark shows potent inhibitory activity against polymorphonuclear leucocytes; the activity is attributed to the alkaloids of the bark. Cinchona may potentiate coumarin derivatives. In large doses, it is sedative to CNS and cardiac plexus. Quinine is toxic at over 3 g, quinidine at 1 g. Related Cinchona sp.: C. calisaya Wedd. (Nilgiris and Sikkim); C. calisaya Wedd. var. ledgeriana How. (West Bengal, Khasi Hills and Tamil Nadu); and C. succirubra Pav. ex Klotz. (Nilgiris and Annamalis in Tamil Nadu, Sikkim and West Bengal). The bark of all the species contain quinine, quinidine, cinchonine and cinchonidine and exhibit antimalarial activity. The alcoholic extract of C. ledgeriana Moens ex Trimen bark exhibits antibacterial activity against Gram-positive bacteria comparable to sodium penicillin. The extract, however, exhibits lesser activity than dihydrostreptomycin sulphate against Gram-negative bacteria.

Botanical Reference 1: Cinchona officinalis — Botanical specimen

Botanical Reference 2: Cinchona officinalis — Botanical specimen

Botanical Reference 3: Cinchona officinalis — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Cinchona officinalis stands as a distinct representative of the genus Cinchona. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Rubiaceae encompasses 40 documented medicinal species (2.21% of the 1,814-species flora). Other representative medicinal members of Rubiaceae include: Adina cordifolia (Haridru), Anthocephalus cadamba (Kadamba), Borreria articularis (Madana-ghanti), Canthium parviflorum (Wild Jasmine), Cephaelis ipecacuanha (Ipecac). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 40 medicinal species of family Rubiaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Cinchona officinalis follow the plant-part modalities specified under its therapeutic action (Antimalarial, febrifuge, astringent, orexigenic, sapasmolytic. Also prescribed in amoebic dysentery, jaundice, atonic dyspepsia, night cramps. Sometimes causes gastric and intestinal irritation), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Cinchona officinalis integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.